reviewJournal of Controlled ReleaseMay 19, 2016HYBRID OA

Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases

University of Beira Interior · Biocant · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

The blood-brain barrier (BBB) is a vital boundary between neural tissue and circulating blood. The BBB's unique and protective features control brain homeostasis as well as ion and molecule movement. Failure in maintaining any of these components results in the breakdown of this specialized multicellular structure and consequently promotes neuroinflammation and neurodegeneration. In several high incidence pathologies such as stroke, Alzheimer's (AD) and Parkinson's disease (PD) the BBB is impaired. However, even a damaged and more permeable BBB can pose serious challenges to drug delivery into the brain. The use of nanoparticle (NP) formulations able to encapsulate molecules with therapeutic value, while…

Citation impact

1,478
total citations
FWCI
70.34
Percentile
100%
References
169
Citations per year

Authors

6

Topics & keywords

Keywords
  • Blood–brain barrier
  • Neuroinflammation
  • Drug delivery
  • Drug delivery to the brain
  • Neuroscience
  • Neurodegeneration
  • Medicine
  • Drug
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding